Verdence Capital Advisors LLC - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 342 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.2%.

Quarter-by-quarter ownership
Verdence Capital Advisors LLC ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$503,217
+6.4%
3,651
+0.0%
0.06%
+5.2%
Q4 2022$472,967
+17.4%
3,6500.0%0.06%
+3.6%
Q3 2022$403,000
+47.1%
3,6500.0%0.06%
+60.0%
Q2 2022$274,000
-3.9%
3,6500.0%0.04%
+9.4%
Q1 2022$285,000
-38.4%
3,650
-35.4%
0.03%
-41.8%
Q4 2021$463,000
+24.5%
5,650
+18.0%
0.06%
+12.2%
Q3 2021$372,000
-11.4%
4,790
-11.3%
0.05%
-15.5%
Q2 2021$420,000
+40.9%
5,400
+35.0%
0.06%
+16.0%
Q1 2021$298,000
-55.7%
4,000
+1.3%
0.05%
-60.9%
Q4 2020$673,000
-35.7%
3,950
-47.0%
0.13%
-46.7%
Q3 2020$1,046,0007,4500.24%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Ikarian Capital, LLC 399,400$35,962,0005.36%
Avoro Capital Advisors LLC 3,125,000$281,406,0004.79%
Varenne Capital Partners 324,661$29,236,0004.34%
Evolutionary Tree Capital Management, LLC 96,695$8,707,0004.18%
Ally Bridge Group (NY) LLC 120,000$10,806,0003.78%
Casdin Capital, LLC 1,350,000$121,568,0003.43%
Ghost Tree Capital, LLC 100,000$9,005,0003.23%
GREAT POINT PARTNERS LLC 145,405$13,094,0002.91%
Camber Capital Management LP 825,000$74,291,0002.55%
Alpha DNA Investment Management LLC 17,522$1,577,0001.00%
View complete list of SAREPTA THERAPEUTICS INC shareholders